Univest
Univest
  • Markets
  • Gland Pharma Share Price: 27.0% CAGR in 3 Years as the Injectables Specialist Faces Divi’s Labs and Cipla

    • November 11, 2026
    • Posted by: Kunal Singla
    • Category: Best Stocks
    No Comments
    Gland Pharma Share Price: 27.0% CAGR in 3 Years as the Injectables Specialist Faces Divi's Labs and Cipla

    Gland Pharma share price compounded at 27.0% a year over 3 years. See how it compares with Divi’s Laboratories and Cipla on returns and valuation.

    read more